Live Breaking News & Updates on Alpert Medical

Stay updated with breaking news from Alpert medical. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

New drug shows promise slowing decline in people with Alzheimer's


PROVIDENCE – A new investigational drug has demonstrated a significant reduction in cognitive deficits in people who are living in the early stages of Alzheimer’s disease, researchers at Butler and Rhode Island hospitals and Brown University have reported in the New England Journal of Medicine.
The drug, donanemab, from pharmaceutical firm Eli Lilly and Company, targets the amyloid plaque and tau protein build-ups in the brain that are associated with the development of Alzheimer’s and other types of dementia.
“This is yet another significant and encouraging milestone in what has proven to be a momentous year in the fight against Alzheimer’s disease,” said Dr. Stephen P. Salloway, one of the paper’s authors and head of Butler’s Memory and Aging Program. “In the last twelve months, we’ve seen significant advancements in diagnosing and treating Alzheimer’s.” ....

Rhode Island , United States , Brown University , Rhode Island Hospital , Rhode Islanders , G Wayne Miller , Martinm Zucker , Daniel Skovronsky , Stephenp Salloway , Eli Lilly , Alpert Medical School , Memory Disorders Center At Rhode Island Hospital , International Conference On Alzheimer Parkinson Disease , Warren Alpert Medical School Of Brown University , Alzheimer Association , New England Journal , Aging Program , Memory Disorders Center , Warren Alpert Medical School , International Conference , Parkinson Disease , Human Behavior , Alpert Medical , ரோட் தீவு , ஒன்றுபட்டது மாநிலங்களில் , பழுப்பு பல்கலைக்கழகம் ,